Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 131,380 | 61,446 | 302,389 | 130,690 | 180,993 |
| Marketable Securities | 481,985 | 597,402 | 420,959 | 278,469 | 269,361 |
| Receivables | 13,662 | 10,765 | 7,481 | 2,353 | 1,351 |
| Inventories | 7,579 | 7,056 | 2,947 | 2,335 | 1,391 |
| TOTAL | $649,101 | $690,905 | $744,866 | $418,573 | $460,973 |
| Non-Current Assets | |||||
| PPE Net | 1,871 | 1,998 | 2,050 | 2,001 | 2,133 |
| Other Non-Current Assets | 23,517 | 24,411 | 24,378 | 20,357 | 18,137 |
| TOTAL | $25,388 | $26,409 | $26,428 | $22,357 | $20,270 |
| Total Assets | $674,489 | $717,314 | $771,294 | $440,931 | $481,243 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,721 | 5,502 | 8,569 | 5,473 | 10,994 |
| Accrued Expenses | 25,408 | 22,804 | 24,192 | 30,796 | 16,871 |
| TOTAL | $39,702 | $36,853 | $38,029 | $40,243 | $31,076 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 22,637 | 23,600 | 23,870 | 21,158 | 19,718 |
| TOTAL | $22,637 | $23,600 | $23,870 | $21,158 | $19,718 |
| Total Liabilities | $62,339 | $60,454 | $61,898 | $61,401 | $50,794 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 81,202 | 80,917 | 80,158 | 67,306 | 66,451 |
| Common Shares | 8 | 8 | 8 | 7 | 7 |
| Retained earnings | -989,844 | -937,104 | -876,405 | -821,221 | -757,509 |
| Other shareholders' equity | 247 | 481 | 768 | 1,169 | -145 |
| TOTAL | $612,150 | $656,860 | $709,396 | $379,530 | $430,448 |
| Total Liabilities And Equity | $674,489 | $717,314 | $771,294 | $440,931 | $481,243 |